ORIGINAL RESEARCH · CLINICIAN & INVESTIGATOR CALL
Propose an original investigation that addresses access, quality, affordability or another meaningful patient-care problem. Bring the clinical question and authorized, organized data; microscopIA joins your research team to contribute agreed methods, analysis, interpretation and manuscript development.
PUBLISH WITH MICROSCOPIA · COLLABORATIVE RESEARCH
Your clinical expertise and microscopIA’s scientific contributions form a shared research project. Our participating researchers take substantive roles in producing, interpreting and reporting credible evidence. Manuscript preparation is one part of that collaboration.
You lead the clinical question, provide complete organized and authorized source material, explain care decisions and outcomes, and participate in interpretation, critical review and final approval. The institution retains custody of its records.
The assigned researchers contribute to the agreed study design, analysis plan, statistical analysis, interpretation and manuscript development, with methodological supervision and documented quality checks. The written scope names the scientific lead and responsibilities before execution.
Together we agree the protocol or case-report plan, contributions, interpretation, journal and final submission. Qualifying authors approve the manuscript and remain accountable for their work. Revisions and responses to reviewers are handled collaboratively within the agreed scope.
Contributions are agreed and recorded, including CRediT roles where applicable. Every proposed author must meet the applicable contribution, drafting or critical-review, final-approval and accountability criteria. Affiliation with microscopIA, supervision, payment or data provision alone does not automatically confer authorship or a byline position.
Review scientific roles and governance →microscopIA · OPEN ACCESS
The ability to pay should not be what determines whether valuable scientific work can reach publication. We assess support within the programme’s conditions.
STUDENTS & YOUNG PROFESSIONALS
Start your own systematic review or meta-analysis as a member. If you need help, request microscopIA assessment for manuscript preparation, open-access publication costs, or both.
Rigorous execution and verifiable methods; completed work is assessed.
Authors, contributions, member percentage, microscopIA and external affiliations.
microscopIA corresponding author and written support scope.
For this member-initiated review route, at least 50% of all genuine authors must be microscopIA Network members with active paid membership. Exactly 50% qualifies for assessment (5 of 10); 3 of 5 is 60%. Memberships are verified during assessment and before funding authorization.
Support depends on high-quality execution and scientific assessment of your question, methods and work completed. Manuscript support and publication-cost support are separate decisions, with scope and covered costs confirmed in writing before expenses are incurred.
Report microscopIA Network members with active paid membership as a percentage of all genuine authors: active members ÷ total authors × 100. The 50% requirement uses the exact counts, not a rounded percentage.
List every author, scientific contributions and all actual affiliations: microscopIA department or group where applicable, plus external institutions, departments, cities and countries. Membership and institutional affiliation are verified separately.
For an approved collaboration, a qualifying microscopIA researcher retains the corresponding-author role, with real scientific contributions, accountability, all-author agreement and compliance with journal rules.
microscopIA assesses applicable open-access agreements through the corresponding author’s genuine, verifiable affiliations. The publisher and participating institution must confirm eligibility and coverage; no agreement or fee waiver is guaranteed.
Prepare your review question and type, protocol or registration if available, methods, evidence of progress, author list and contributions, total authors and active-member count. Indicate the support needed and any proposed journal or fee estimate; these may be unknown.
Authorship follows actual scientific contributions. Do not add authors to meet the threshold. A request does not guarantee support, journal acceptance or publication.
For approved projects developed within microscopIA, the organization may cover the agreed publication costs under the applicable programme conditions. Existing written commitments to cover approved charges remain in force.
As an experienced Clinicians & Investigators member, propose a systematic review or meta-analysis with the microscopIA network and request open-access publication-cost support when MORE THAN 30% of the qualifying authors have a verified active microscopIA affiliation.
The threshold allows a support request; it does not automatically grant funding. Scientific review and written approval must confirm the journal, covered amount, exclusions and payment procedure before costs are incurred. Membership alone does not establish affiliation or authorship. Affiliations must be genuine and authorship follows actual contributions. Journal acceptance is independent.
Publication-cost support is distinct from membership subscriptions, project fees and accelerated preparation. Clinical-call fees remain applicable unless a written agreement expressly changes them.
YOUR QUESTION FIRST. A TRANSPARENT COLLABORATION NEXT.
Qualified clinicians and investigators may propose a case report or original study with or without membership. Submit immediately for scientific evaluation at no charge; these time-limited calls do not require waiting for a completed membership proposal window. Membership offers a lower project fee; it does not purchase selection or authorship.
| Region | Professional member | Nonmember · 3× |
|---|---|---|
| Colombia | USD 350USD 150 after approval + signed scopeUSD 200 at journal publication | USD 1,050USD 450 after approval + signed scopeUSD 600 at journal publication |
| Other Americas · excludes Colombia, USA and Canada | USD 525USD 225 after approval + signed scopeUSD 300 at journal publication | USD 1,575USD 675 after approval + signed scopeUSD 900 at journal publication |
| International · includes USA and Canada | USD 787.50USD 337.50 after approval + signed scopeUSD 450 at journal publication | USD 2,362.50USD 1,012.50 after approval + signed scopeUSD 1,350 at journal publication |
USD 450 after approval and signed agreement + USD 600 at journal publication, not acceptance or preprint.
Due today: USD 0. No second installment for journal rejection.
Professional membership: international USD 70/month, billed separately. Eligible Colombian citizens have a separate COP 200,000/month route. Project fees above are additional. Regional project eligibility and subscription eligibility are reviewed separately.
Member project fees are two-thirds lower than nonmember fees. Your overall cost also depends on recurring membership, taxes and any separately agreed costs; savings are not guaranteed. Confirm active-membership and continuity conditions in writing before activation.
Compare membership and activate →Use the same scientific review. Indicate your participation route in the proposal. Membership and regional pricing are verified manually before the written agreement; this calculator is not a binding quote.
Propose my project — no payment now →New case-report and original-research proposals use member project rates or standard nonmember rates (3×). Membership is a separate recurring subscription, not free project execution. No additional 30% discount stacks with these call rates. Existing accepted benefits and signed agreements are preserved; no retrospective charges. Scientific approval, organized authorized inputs and written scope are required. Students & Young Professionals cannot lead these calls. The AI image collaboration retains its separate member-only eligibility and commercial terms.
The written scope confirms the clinical lead, regional route, tax treatment, analysis complexity, deliverables, capacity, journal/APC budget covered by microscopIA, withdrawal/refunds and membership verification. Patient care, laboratory work, data organization and unlimited third-party costs are not included. Mixed-country teams require a written regional determination. Acceleration requires a separate feasibility assessment and written quote; the general publication-support simulator is a separate service and its discounts or payment triggers do not apply to these calls.
RESEARCH CALLS · CLINICIANS & INVESTIGATORS
A private preparation guide, not scientific approval. Answers stay in this page session; no patient information is requested or submitted.
A relevant question, a complete organized dataset and institutional data permissions.
CLINICIAN-LED QUESTIONS · SCIENTIFIC INDEPENDENCE
Priority goes to feasible evaluations of clinician-led approaches to unmet patient needs, including appropriately governed off-label practice, affordable alternatives, care pathways and quality improvements. Novelty alone is insufficient. Studies with negative or inconclusive findings are equally eligible.
Retrospective cohorts, case-control and cross-sectional studies, existing observational datasets and authorized secondary analyses may be assessed. The ethics body determines whether approval, consent or an applicable waiver is required. An institutional data-owner permission is necessary but does not replace ethics review.
A proposal or membership does not authorize treatment, recruitment or a trial. Any research that prospectively assigns an intervention requires its own protocol, ethics and applicable regulatory approvals, and prospective trial registration when applicable. Do not change care to qualify for this call.
A relevant example is microscopIA’s multicenter real-world evaluation of ketorolac/nepafenac prophylaxis in retinopathy of prematurity. Its public research record illustrates a question and evaluation pathway; it is not a treatment recommendation or proof of universal effectiveness.
Explore the ROP research programme →REQUIRED BEFORE SCIENTIFIC ACCEPTANCE
The clinician/investigator is responsible for collecting, organizing and documenting the dataset. microscopIA does not accept low-quality or unorganized datasets and does not organize, reconstruct or extract clinical data under this call.
microscopIA checks scientific suitability and data quality before acceptance. Incomplete or unsuitable material is returned or declined; submitting it does not create a duty to organize it. Preparation targets start only with approved scope and complete authorized inputs.
No datasets, images, records or patient identifiers in the application.
Study-design and analysis planning, data-quality acceptance checks, statistical analysis, interpretation with the clinical team, manuscript preparation, appropriate reporting guidelines, journal selection and submission coordination. microscopIA covers publication charges at the agreed journal within the written approved budget.
Research question and analysis plan; dataset feasibility; assigned team and supervision; deliverables and timetable; member or nonmember project rate; protected existing agreements; journal/APC budget and payer; revisions, journal changes, taxes, withdrawal and unearned-fee refunds. Patient-care, laboratory, recruitment or other third-party costs are covered only if expressly budgeted.
Selection is independent of payment. Authorship requires qualifying contributions, review, final approval and accountability. No paper count, positive result, authorship position, journal acceptance or publication date is guaranteed.
FIRST PUBLICATION? START HERE
We assess the question, organized inputs, permissions, included allowance and feasible scope. This is not journal acceptance.
The accepted team completes the agreed work. Authors review the interpretation, disclosures and final manuscript before approving submission.
Editors may reject without peer review, request changes or invite external reviewers. Revisions, additional analyses or a new journal may be needed; changes of scope or budget require agreement.
Acceptance is an editorial decision. Proof correction, production and online publication follow, often on a separate timetable. A preprint is not a journal publication; indexing is not automatic.
Membership, fees, data contribution or clinical seniority do not guarantee acceptance, authorship, author position, impact factor or publication date.
Authorship requires substantive contributions, drafting or critical review, final approval and accountability. Anonymization does not automatically remove consent or ethics obligations. Journal charges are covered only at the agreed journal within the approved scope and budget; no undisclosed extras. Negative or inconclusive results must not be hidden.
For new paid call projects, the first installment follows written approval and agreement; the second follows journal publication of the article, not acceptance or preprint posting. Existing accepted benefits and signed agreements are preserved without retrospective charges.
Research integrity and responsibilities →Preparation follows scientific approval and activation with complete authorized inputs. The written scope records the start date, materials, milestones and any agreed changes. Journal review, acceptance and publication take additional independent time.
Explore accelerated preparation →The simulator offers accelerated and preferential preparation targets, subject to feasibility and a separate written agreement. Its commercial estimate is not automatically a supplement for an included benefit: coordination must reconcile the included work first. No duplicate charge; no accelerated journal decision is promised.
PROPOSE · REVIEW · AGREE · EXECUTE
Use your professional contact email; members should use their membership account email. Indicate member, nonmember or an existing accepted agreement. The form does not automatically verify membership. The team reviews eligibility, question, data quality, ethics and feasibility, then confirms acceptance and written scope before data transfer or payment. Preliminary questions before joining are welcome and do not reserve a place.
Scientific coordination: Jorge Racedo · biomedical engineer, microscopIA.
Ask about scientific fit without patient information ↗Research governance · Declaration of Helsinki · ICMJE · STROBE
